Efficacy of SGLT2 Inhibitors in Patients With Diabetes and Nonobstructive Hypertrophic Cardiomyopathy. Subramanian M, Sravani V, Krishna SP, Bijjam S, et al. Am J Cardiol 2022;188:80-86.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Subramanian M, Sravani V, Krishna SP, Bijjam S, et al. Efficacy of SGLT2 Inhibitors in Patients With Diabetes and Nonobstructive Hypertrophic Cardiomyopathy. Am J Cardiol 2022;188:80-86.
PMID: 36473308